Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.22%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +34.95%
#5 Humanity Humanity +26.29%
#6 Codatta Codatta +19.83%
#7 Walrus Walrus +18.24%
#8 Enso Enso +17.51%
#9 RedStone RedStone +16.76%
#10 Collector Crypt Collector Crypt +14.50%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
4Front Ventures Corp. 4Front Ventures Corp.

4Front Ventures Corp.

FFNT
Rank in Stocks #36725
4Front Ventures Corp. manages and operates authorized cannabis enterprises... 4Front Ventures Corp. manages and operates authorized cannabis enterprises across various state-regulated markets in the United States. Its business is divided into two main categories: THC Cannabis and CBD Wellness. The company is actively involved in cultivating, producing, distributing, and selling both cannabis and cannabidiol products. As of December 31, 2021, it oversaw six retail dispensaries primarily branded as MISSION, located in Massachusetts, Illinois, and Michigan. In addition to its core cannabis and CBD activities, 4Front Ventures supplies equipment, materials, and intellectual property to other cannabis cultivators; imports and distributes these supplies; leases properties to cannabis businesses; and provides expert consulting services. Founded in 2011, the company is headquartered in Phoenix, Arizona.
Share Price
$0.0036439
Last synced: 2025-06-03
Market Cap
$2.38M
Change (1 day)
-0.04%
Change (1 year)
0.00%
Country
US
Trade 4Front Ventures Corp. (FFNT)

Category

Healthcare
P/E ratio for 4Front Ventures Corp. (FFNT)
P/E ratio as of 2026 TTM: 0
According to 4Front Ventures Corp. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for 4Front Ventures Corp. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.